Jaguar Health, Inc. - stock earnings

JAGX Quarterly earnings

DateEarningsRevenue
2023Q3 -7.8 million USD 2.8 million USD
2023Q2 -12.2 million USD 2.7 million USD
2023Q1 -12.2 million USD 2.0 million USD
2022Q4 -7.4 million USD 3.3 million USD
2022Q3 -12.5 million USD 3.2 million USD
2022Q2 -9.4 million USD 2.9 million USD
2022Q1 -18.0 million USD 2.6 million USD
2021Q4 -14.3 million USD 2.1 million USD
2021Q3 -12.2 million USD 630000 USD
2021Q2 -14.1 million USD 385000 USD
2021Q1 -12.0 million USD 1.2 million USD
2020Q4 -8.8 million USD 2.6 million USD
2020Q3 -7.9 million USD 2.8 million USD
2020Q2 -9.2 million USD 3.2 million USD
2020Q1 -6.0 million USD 1.5 million USD
2019Q4 -6.0 million USD 1.5 million USD
2019Q3 -7.6 million USD 972779 USD
2019Q2 -16.7 million USD 1.7 million USD
2019Q1 -12.7 million USD 1.6 million USD
2018Q4 -12.7 million USD 1.6 million USD
2018Q3 -6.1 million USD 1.1 million USD
2018Q2 -7.7 million USD 883846 USD
2018Q1 -20.2 million USD 1.5 million USD
2017Q4 -20.2 million USD 1.5 million USD
2017Q3 4.8 million USD 1.1 million USD
2017Q2 -1.8 million USD 896521 USD
2017Q1 -4.7 million USD 822410 USD
2016Q4 -3.7 million USD 28877 USD
2016Q3 -3.4 million USD 50357 USD
2016Q2 -3.7 million USD 24143 USD
2016Q1 -4.0 million USD 38146 USD
2015Q4 -4.1 million USD 55186 USD
2015Q3 -3.0 million USD 77666 USD
2015Q2 -5.3 million USD 63142 USD
2015Q1 -3.9 million USD 62387 USD
2014Q4 -2.0 million USD ? USD
2014Q3 -2.7 million USD ? USD
2014Q2 -1.9 million USD ? USD
2014Q1 -2.0 million USD ? USD

JAGX Yearly earnings

DateEarningsRevenue
2023 -39.7 million USD 10.7 million USD
2022 -47.5 million USD 12.0 million USD
2021 -60.3 million USD 4.3 million USD
2020 -36.8 million USD 9.4 million USD
2019 -38.5 million USD 5.8 million USD
2018 -32.1 million USD 4.4 million USD
2017 -22.0 million USD 4.4 million USD
2016 -14.7 million USD 141523 USD
2015 -16.3 million USD 258381 USD
2014 -8.6 million USD ? USD
2007 -25.5 million USD 303297 USD

JAGX

Price: $0.18

52 week price:
0.05
1.22

Earnings Per Share: -0.87 USD

P/E Ratio: -0.11

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 617552

Ebitda: -16.5 million

Market Capitalization: 20.9 million

Links: